Hence, we conducted this study to elucidate the nuanced relationship between circulating ACE2 concentrations at the onset of sepsis and subsequent clinical outcomes, potentially offering valuable insights into the evolving landscape of critical care. The gene discussed is ACE2; the disease is Sepsis.